Cervical Screening Documentation Unit

宫颈筛查文档中心

• 批准号: 8729299
• 负责人: Cosette M Wheeler
• 金额: $ 28.95万
• 依托单位: UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-06-01 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8729299
• 关键词: Cervical; Screening; Documentation; Unit

C. PROJECT SUMMARY The NMHPVPR monitors the complete continuum of cervical cancer prevention in New Mexico and Is the only population-based, woman-based, cervical screening registry In the U.S. Using clinically relevant electronic medical records (EMR), detailed woman-based information including text dictations is generated for cervical cancer screening, diagnosis and treatment delivered throughout New Mexico. All results of tests whether positive or negative, normal or abnormal are transmitted to the NMHPVPR under state mandate. This unique public health resource serves as the cornerstone of the NM-HOPES-PRC Cervical Cancer Screening Process Documentation Unit. The NMHPVPR information systems, which are fully electronic, transcend organizational structures of healthcare. Reporting to the NMHPVPR is conducted at a national, regional and statewide level and is based at the individual woman and provider levels. By comparison to organizational systems such as Managed Care Organizations (MCO), which suffer both loss from area out-migration and loss to membership due to personal decisions or changes in employer insurance agreements, the NMHPVPR only suffers out-migration from the entire state of New Mexico. New Mexico incurs and average outmigration by comparison to other states, it is 27th In the nation. The NMHPVPR embodies the entire spectrum of clinical practice delivery of cervical cancer prevention Including Indian Health Service Facilities, an MCO, multiple health plans, community-based practice networks and Individual provider practices in largely isolated areas of the state. The annual woman-based data contributions from the NMHOPES from the entire state of New Mexico represent ~225,000 cervical cancer screening Pap events (plus abnormal referral Paps) and an average of over 18,000 diagnostic colposcopy and LEEP treatment visits including clinic visits with cervical, vaginal, vulvar or endometrial biopsy procedures. Beyond the innovations of the NMHPVPR, in anticipation of PROSPR directions and needs, we have engaged specific partnerships with a number of clinic networks who deliver care to the underserved and impoverished Hispanic and American Indian women of our state who are at high risk for invasive cervical cancer. In our selected clinical provider network partnerships, over 30,000 screening Pap tests are delivered each year and over 40,000 individual women screen in a 3-year period versus an estimated 57,000 screen-eligible women. Based on the HEDIS quality measures for cervical cancer (i.e., PAP testing within the measurement year or prior 2 years), our partnering practices deliver cervical cancer screening at varying levels ranging from 68%-72% of their screen-eligible patients. We have specifically partnered with a range of clinical settings to provide broad opportunities to the PROSPR Consortium. Our research projects target gaps in knowledge to enable future interventions to improve cervical cancer prevention.

C.项目摘要 NMHPVPR监视新墨西哥州宫颈癌预防的完整连续性 在美国，唯一的基于人群的，基于女性的宫颈筛查注册表使用临床 相关的电子病历（EMR），基于妇女的详细信息，包括文本说法 用于整个新墨西哥州进行的宫颈癌筛查，诊断和治疗。全部 测试的结果是正面或负，正常或异常的测试结果。 国家任务。这种独特的公共卫生资源是NM-Hopes-PRC的基石 宫颈癌筛查过程文档单位。 NMHPVPR信息系统， 完全电子，超越医疗保健组织结构。向NMHPVPR报告 在国家，地区和全州层面，以个人和提供者的层面为基础。经过 与托管护理组织（MCO）等组织系统的比较，这两种损失 由于个人决定或雇主保险的变化，从地区外移民和损失到会员资格 协议，NMHPVPR仅遭受整个新墨西哥州的迁移。新墨西哥州 相比之下，与其他州相比，这是全国第27位。 NMHPVPR 体现了包括印度健康在内的宫颈癌预防的整个临床实践传递 服务设施，MCO，多个健康计划，基于社区的实践网络和个人提供商 该州在很大程度上孤立的地区的做法。 NMHopes的年度基于女性的数据贡献 来自整个新墨西哥州的整个州代表约225,000个宫颈癌筛查子公司（另外 异常推荐PAPS）和平均18,000多个诊断性阴道镜和LEEP治疗访问 包括宫颈，阴道，外阴或子宫内膜活检程序的诊所就诊。超越创新 在NMHPVPR的情况下，为了期待ProSPR的指示和需求，我们已经参与了特定的合作伙伴关系 有许多诊所网络，他们为服务不足和贫穷的西班牙裔和贫困 我们州的美洲印第安妇女患有侵入性宫颈癌的高风险。在我们选定的临床中 提供商网络合作伙伴关系，每年进行30,000多个筛选子宫颈抹片检查，超过40,000个 在3年的单个女性屏幕上，估计有57,000名符合屏幕的女性。基于 宫颈癌的HEDIS质量指标（即在测量年内或前2年内的子宫颈抹片检查）， 我们的伴侣实践提供的宫颈癌筛查的水平不同，范围从68％-72％ 符合筛查的患者。我们专门与一系列临床环境合作，提供广泛的 ProSPR联盟的机会。我们的研究项目针对知识的差距，以使未来 改善宫颈癌预防的干预措施。